Founding Partner
AI-powered health technologies can be protected through a mix of patents, trade secrets, copyrights, and carefully drafted data-use agreements. The strongest strategies usually focus on safeguarding algorithms, training data, clinical outputs, and the underlying hardware or software integrations. By understanding where the true value lies in your innovation, you can put protections in place that keep competitors from copying your work and ensure long-term commercial strength.
Why IP Protection Matters for AI Health Technologies
AI-driven medical tools combine software, data, and biomedical functions in ways that create multiple layers of intellectual property. Protecting these layers is challenging because patent eligibility rules continue to evolve, and many AI models rely on data sets that cannot be publicly disclosed. A strategic approach helps you secure rights in the invention itself, the model’s training pipeline, and the outputs that attract commercial interest.
What Parts of an AI-Driven Health Tool Can Be Patented?
Most AI health tech innovators want patent protection, but the path varies depending on the nature of the invention. Examiners are cautious about algorithm-only claims, so your strategy often depends on emphasizing how the innovation improves a diagnostic, therapeutic, or clinical workflow.
Patent protection may be available for:
- Clinical devices that integrate AI with sensors or medical hardware
- Diagnostic or predictive models that transform real patient data into actionable outputs
- Novel data-processing steps that materially improve accuracy or efficiency
- Systems that combine software and physical components in a unified diagnostic solution
Patent eligibility often depends on showing how the invention improves a medical process or produces a concrete technical benefit. Examiners look for practical applications, measurable performance gains, or clear technological solutions within the clinical setting. The more specific and demonstrable the improvement, the stronger the chances of securing a patent.
Using Trade Secrets to Protect Models and Training Data
Some health tech companies prefer to keep their algorithms and data sets confidential rather than publicly disclose them in a patent application. Trade secrets can be especially valuable if:
- Your competitive advantage depends on proprietary data sources
- The model’s success relies on unique weighting, parameter tuning, or training pipelines
- You use large clinical data sets that cannot be revealed due to regulatory or privacy restrictions
To maintain protection, you must take reasonable steps to limit access. That often involves technical safeguards, internal access controls, and strict confidentiality agreements. If someone misappropriates a trade secret despite these safeguards, you can seek remedies under state and federal law, including the Defend Trade Secrets Act.
Protecting Software, Code, and User Interfaces With Copyright
Although copyrights cannot protect the underlying algorithmic idea, they can safeguard the expression of that idea in your code, interface elements, and documentation. This becomes especially important when AI health tools involve:
- Custom user dashboards for clinicians
- Software modules that integrate with hospital electronic record systems
- Training manuals, protocols, or visualization outputs
Copyright is a useful secondary layer of protection. We often recommend using it together with patents or trade secrets so you have coverage across both form and function.
Handling Training Data, PHI, and Data-Use Rights
AI health technologies depend heavily on high-quality clinical data. The agreements governing this data are just as important as the invention itself. If you do not control your data sources, your ability to build, refine, or defend the innovation may be weakened.
Key agreements often include:
- Data-use agreements with hospitals, research institutions, or clinical partners
- HIPAA-compliant frameworks for handling protected health information
- Licensing terms for using third-party data sets in model training
- Clear boundaries around how outputs can be commercialized
Strong data rights put you in a better position to enforce your IP and respond to potential infringement.
When to File Provisional vs. Non-Provisional Patent Applications
Timing matters, especially in fast-moving health tech markets. A provisional application allows you to secure an early filing date while gathering performance data or clinical validation.
A non-provisional application should be filed when:
- Your technology provides specific, demonstrable improvements
- You have evidence of accuracy, sensitivity, or specificity
- Your data-processing steps are fixed enough to claim with confidence
Filing too early may limit your claims, but waiting too long can result in competitors filing first or publishing similar work.
How Regulatory Pathways Affect IP Strategy
The FDA’s evolving framework for AI-based medical devices impacts how patents are drafted and when filings should occur. If your innovation adapts or retrains over time, you may need an IP strategy that covers:
- Static features of the model
- Adaptive components that update based on new data
- Safety-related improvements
- Continuous learning processes
We encourage clients to think about how regulatory submissions and patent applications interact so disclosures do not weaken claim scope later.
Work With Gearhart Law to Protect Your AI Health Tech Innovation
AI health technologies raise unique IP challenges, but you do not have to figure them out alone. Gearhart Law helps innovators secure patents, protect proprietary data, structure strong licensing agreements, and defend their competitive advantage. If you are developing an AI-driven medical tool, we will guide you through your protection options and build a strategy that fits your long-term goals.
Contact Gearhart Law today to discuss your AI health tech innovation and learn how we can support your next steps.